Paper · 42417552

In vitro and in vivo models for androgenetic alopecia drug development.

Tu S and 7 others. Dis Model Mech, 2026. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. In vitro and in vivo models for androgenetic alopecia drug development. Papers, record 42417552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42417552

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: In vitro and in vivo models for androgenetic alopecia drug development.; PubMed
Journal: Dis Model Mech; PubMed
Year: 2026; PubMed
Publication types: Journal Article, Review; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/42417552/; PubMed
DOI: https://doi.org/10.1242/dmm.052848; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC13382705/; PubMed
The journal: https://conductscience.org/library/journal-index/101483332; PubMed
Citations, by iCite: 1; iCite
Revised in PubMed: 2026-08-13; PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	ORCID iD
1	Tu S	Shan
2	Nanmo A	Ayaka
3	Migita Y	Yuki
4	Asaba T	Tomoki
5	Seo J	Jieun
6	Hamano S	Sayuri
7	Kageyama T	Tatsuto
8	Fukuda J	Junji	https://orcid.org/0000-0002-7194-8099

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Alopecia	Major topic
Drug Development	Major topic
Models, Biological	Major topic
Humans
Animals
Disease Models, Animal
Hair Follicle

Source PubMed

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Stated by
	Kanagawa Institute of Industrial Science and Technology (KISTEC)	PubMed
23K13614	Japan Society for the Promotion of Science (KAKENHI)	PubMed
23H01771	Japan Society for the Promotion of Science (KAKENHI)	PubMed
23bm1123031h0001	Japan Agency for Medical Research and Development	PubMed
	Yokohama National University	PubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References126

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	22,797,912	Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues.	J Cell Sci	2012	https://conductscience.org/library/papers/22797912	PubMed
2	38,324,888	The development of anin vitrohuman hair follicle organoid with a complexity similar to thatin vivo.	Biomed Mater	2024	https://conductscience.org/library/papers/38324888	PubMed
3	22,409,453	Minoxidil use in dermatology, side effects and recent patents.	Recent Pat Inflamm Allergy Drug Discov	2012	https://conductscience.org/library/papers/22409453	PubMed
4	8,006,447	Alopecia areata in aging C3H/HeJ mice.	J Invest Dermatol	1994	https://conductscience.org/library/papers/8006447	PubMed
5	31,400,254	Physiopathology and current treatments of androgenetic alopecia: Going beyond androgens and anti-androgens.	Dermatol Ther	2019	https://conductscience.org/library/papers/31400254	PubMed
6	21,167,691	Molecular basis of androgenetic alopecia: From androgen to paracrine mediators through dermal papilla.	J Dermatol Sci	2011	https://conductscience.org/library/papers/21167691	PubMed
7	22,960,356	Mesenchymal-epithelial interactions during hair follicle morphogenesis and cycling.	Semin Cell Dev Biol	2012	https://conductscience.org/library/papers/22960356	PubMed
8	31,343,406	Skin vasculature and hair follicle cross-talking associated with stem cell activation and tissue homeostasis.	Elife	2019	https://conductscience.org/library/papers/31343406	PubMed
9	35,938,157	Hair Follicle Morphogenesis During Embryogenesis, Neogenesis, and Organogenesis.	Front Cell Dev Biol	2022	https://conductscience.org/library/papers/35938157	PubMed
10	34,159,872	Minoxidil: a comprehensive review.	J Dermatolog Treat	2022	https://conductscience.org/library/papers/34159872	PubMed

1 to 10 of 126

See all 126 references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMID	Title	Journal	Year	In Papers
42,422,890	Enhancing the in vitro architecture of human disease.	Dis Model Mech	2026	https://conductscience.org/library/papers/42422890

Source PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42417552

GET https://conductscience.org/api/papers/v1/42417552/references?page=2

API reference For AI assistants